Vaccine roll-out working in Scotland, first national study suggests
Vaccination has been linked to a substantial reduction in the risk of COVID-19 admissions to Scotland's hospitals, landmark research suggests.
Feb 22, 2021
0
3
Vaccination has been linked to a substantial reduction in the risk of COVID-19 admissions to Scotland's hospitals, landmark research suggests.
Feb 22, 2021
0
3
COVID-19 vaccine passports could be created, but significant challenges need to be overcome first, according to a report today from a panel led by Oxford Professors Melinda Mills and Chris Dye, which outlines a dozen issues ...
Feb 19, 2021
0
2
Israel's largest healthcare provider said Sunday a study of more than half a million fully vaccinated Israelis indicated the Pfizer/BioNTech jab gave 94 percent protection against COVID-19.
Feb 14, 2021
0
362
A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal ...
Feb 8, 2021
0
8
Germany's health ministry on Tuesday joined AstraZeneca in rubbishing reports quoting unnamed government sources that claimed the British-Swedish company's COVID-19 vaccine showed little efficacy for people above 65.
Jan 26, 2021
0
3
The COVID-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said on Sunday.
Dec 27, 2020
0
20
Coronavirus vaccines are being administered. Pfizer's COVID-19 vaccine was the first to finish the final stage of testing—known as phase 3—and the full results have been published. Having assessed the data, countries ...
Dec 21, 2020
0
3
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases—with vaccine efficacy of 62% for those given two full doses, and of 90% in those given a half ...
Dec 8, 2020
0
30
Pfizer confirmed Friday and that it and partner BioNTech have applied for emergency use authorization for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world.
Nov 20, 2020
0
3
It's been a busy week or so for news about COVID vaccines. First we heard preliminary clinical trial results from the Pfizer vaccine, then the Russian Sputnik V vaccine. This week, we heard about the Moderna vaccine. All ...
Nov 19, 2020
0
2